Apostol AI, Gronwald J, Cybulski C, Kim RH, Møller P, Karlan BY, Bordeleau L, Schrader I, Ramón Y Cajal T, Pal T, Eisen A, Singer CF, Couch FJ, Zakalik D, Metcalfe K, Olopade O, Tung N, Fruscio R, Foulkes WD, Aeilts A, Sun P, Lubinski J, Narod SA, Kotsopoulos J, Hereditary Breast Cancer Clinical Study Group(2026) Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2 J Clin Oncol, JCO2501648(in press) DOI 10.1200/JCO-25-01648, PubMed 41762747
Martin Agudo M, Van der Pol H, Bratseth Stav G, Kringelbach T, Puco K, Flobak Å, Gelderblom H, Taskén K, Fagereng GL, Hovig E, PRIME-ROSE Consortium(2026) 'Crossing borders' in data standardisation: application of OMOP CDM in an international clinical trial network in precision cancer medicine Acta Oncol, 65, 159-163 DOI 10.2340/1651-226X.2026.45120, PubMed 41733536
Darbandi S, Urbanucci A, Hakkola S, Gujral J, Darbandi M, Eraky A, Nair S, Chakraborty G, Tewari A, Kyprianou N(2026) Happening in the Prostate Tumor Microenvironment: Ion Channels and Extrachromosomal DNA Driving Phenotypic Plasticity Prostate(in press) DOI 10.1002/pros.70139, PubMed 41632930
